7
Total investments
1
Early stage
0
Mid stage
0
Late stage
6y
Years active
Portfolio
6 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
First check Investor
Sep 2025
Our mission is to cure endometriosis.
We are a team of interdisciplinary scientists creating a new model in womens health research centred around an in depth understanding of tissue-level disease processes. We are committed to improving the quality of life of women by providing a new model for therapeutic discovery. We sit at the interface between tissue biology, computation and laboratory disease modelling.
Founding Team and Investor
Jan 2024
U-Ploid is a biotechnology company developing next-generation fertility therapeutics to address the global challenge of age-related infertility. Co-founded by leading scientists and industry experts, U-Ploid is pioneering innovative solutions to improve IVF outcomes and expand the window of reproductive opportunity. The companys technology is designed to increase the quality of older eggs, restoring their potential to support healthy pregnancies. U-Ploid is committed to improving access to fertility care and envisions a future where anyone who wants to start a family, can.
Founding Team and Investor
Apr 2023
Proxima Fusion is Europes leading fusion company, building the first generation of stellarator fusion power plants.
Founding Team and Investor
Oct 2021
We transform inexpensive, readily available metals into high-performing nanomaterials critical for producing green fuels and clean energy solutions. Our Midas-touch alloys replicate the functional properties of platinum-group metals at just one tenth of the cost. Milvus is the pioneer in creating substitutes for platinum-group metals at the nanoscale, enabling high-performance catalysis and driving advancements in sustainable technology.
Founding Team and Investor
Jul 2021
Getting genetic syntax right.
With precise use of genetic grammar in transgenic design, ExpressionEdits unlocks the capacity to make proteins previously beyond reach.
Experience · 11 entries
All (11)
Investments (7)
Founder (2)
Board (1)
2025
First check Investor
Sep 2025
Our mission is to cure endometriosis.
We are a team of interdisciplinary scientists creating a new model in womens health research centred around an in depth understanding of tissue-level disease processes. We are committed to improving the quality of life of women by providing a new model for therapeutic discovery. We sit at the interface between tissue biology, computation and laboratory disease modelling.
2024
Founding Team and Investor
Jan 2024
U-Ploid is a biotechnology company developing next-generation fertility therapeutics to address the global challenge of age-related infertility. Co-founded by leading scientists and industry experts, U-Ploid is pioneering innovative solutions to improve IVF outcomes and expand the window of reproductive opportunity. The companys technology is designed to increase the quality of older eggs, restoring their potential to support healthy pregnancies. U-Ploid is committed to improving access to fertility care and envisions a future where anyone who wants to start a family, can.
2023
Founding Team and Investor
Apr 2023
Proxima Fusion is Europes leading fusion company, building the first generation of stellarator fusion power plants.
2021
Founding Team and Investor
Oct 2021
We transform inexpensive, readily available metals into high-performing nanomaterials critical for producing green fuels and clean energy solutions. Our Midas-touch alloys replicate the functional properties of platinum-group metals at just one tenth of the cost. Milvus is the pioneer in creating substitutes for platinum-group metals at the nanoscale, enabling high-performance catalysis and driving advancements in sustainable technology.
Co-Founder
Sep 2021
We create and operate the best laboratories and innovation spaces for science, engineering and deep-tech ventures. Whether its a single bench in a shared lab, a dedicated floor to full building, we provide everything builders need to focus on what matters most: their work.
With operations led in UK and Italy, we are expanding further in Europe and the US. We believe that innovation advances in collaboration: we develop and run our infrastructure through Management and Service agreements, ensuring full alignment between capital, real estate, operations and the final user.
WilbeLABS is part of Wilbe, the venture firm where scientists and engineers build generational companies.
Show all 11 entries ↓
Investment activity
2020–2025 · 7 investments
Recent (last 2 years)Earlier
